Skip to main content

Antifungal Treatment (Topical/Systemic)

  • Chapter
  • First Online:
Nasal Polyposis

Abstract

The exact origin of chronic rhinosinusitis (CRS) is still unknown. The disease is most likely to be caused and maintained by multiple factors. A recent theory suggested fungi to be significantly implicated in the generation of CRS and nasal polyposis (NP). Preliminary reports suggested that topical antifungal treatment improved NP and CRS, whereas randomized, blinded, and placebo-controlled trials did not find antifungal lavages or sprays to be better than saline. Similarly, systemic antifungal treatment did not show any effect on CRS. Despite disappointing clinical trials, there is evidence that amphotericin B efficacy (a) depends upon the dosage and duration used and (b) probably acts via a selective cytotoxic effect on NP cells, rather than its antifungal properties. Whatever the future of amphotericin B in rhinology, one must not forget that this drug has side effects and that extensive use might induce resistances.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 189.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Barker KS, Crisp S, Wiederhold N, Lewis RE, Bareither B, Eckstein J et al (2004) Genome-wide expression profiling reveals genes associated with amphotericin B and fluconazole resistance in experimentally induced antifungal resistant isolates of Candida albicans. J Antimicrob Chemother 54(2):376–385

    Article  PubMed  CAS  Google Scholar 

  2. Bent JP III, Kuhn FA (1996) Antifungal activity against allergic fungal sinusitis organisms. Laryngoscope 106(11): 1331–1334

    Article  PubMed  Google Scholar 

  3. Corradini C, Del Ninno M, Buonomo A, Nucera E, Paludetti G, Alonzi C, Sabato V, Schiavino D, Patriarca G (2006) Amphotericin B and lysine acetylsalicylate in the combined treatment of nasal polyposis associated with mycotic infection. J Investig Allergol Clin Immunol 16(3):188–193

    PubMed  CAS  Google Scholar 

  4. Ebbens FA, Scadding GK, Badia L, Hellings PW, Jorissen M, Mullol J, Cardesin A, Bachert C, van Zele TP, Dijkgraaf MG, Lund V, Fokkens WJ (2006) Amphotericin B nasal lavages: not a solution for patients with chronic rhinosinusitis. J Allergy Clin Immunol 118(5):1149–1156

    Article  PubMed  CAS  Google Scholar 

  5. Ebbens FA, Georgalas C, Rinia AB, van Drunen CM, Lund VJ, Fokkens WJ (2007) The fungal debate: where do we stand today? Rhinology 45(3):178–189

    PubMed  CAS  Google Scholar 

  6. Fokkens W, Lund VJ, Bachert C, Clement P, Hellings P, Holmstrom M, Jones N, Kalogjera L, Kennedy DW, Kowalski M, Malmberg H, Mullol J, Passali D, Stammberger H, Stierna P (2005) EPOS – European position paper on rhinosinusitis and nasal polyposis. Rhinology Suppl 18:1–88

    Google Scholar 

  7. Fokkens W, Lund V, Mullol J (2007) EP3OS 2007: European position paper on rhinosinusitis and nasal polyps 2007. A summary for otorhinolaryngologists. Rhinology 45(2): 97–101

    PubMed  Google Scholar 

  8. Gosepath J, Grebneva N, Mossikhin S, Mann WJ (2002) Topical antibiotic, antifungal, and antiseptic solutions decrease ciliary activity in nasal respiratory cells. Am J Rhinol 16(1):25–31

    PubMed  Google Scholar 

  9. Hartsel SC, Benz SK, Ayenew W, Bolard J (1994) Na+, K+ and Cl− selectivity of the permeability pahways induced through sterol-containing membrane vesicles by amphotericin B and other polyene antibiotics. Eur Biophys J 23(2): 125–132

    Article  PubMed  CAS  Google Scholar 

  10. Helbling A, Baumann A, Hanni C, Caversaccio M (2006) Amphotericin B nasal spray has no effect on nasal polyps. J Laryngol Otol 120(12):1023–1025

    Article  PubMed  CAS  Google Scholar 

  11. Hofer E, Neher A, Schrott-Fischer A, Nagl M (2004) Influence of amphotericin B on the ciliary beat frequency of nasal mucosa. Laryngoscope 114(11):1964–1966

    Article  PubMed  CAS  Google Scholar 

  12. Jen A, Kacker A, Huang C, Anand V (2004) Fluconazole nasal spray in the treatment of allergic fungal sinusitis: a pilot study. Ear Nose Throat J 83(10):693–695

    Google Scholar 

  13. Jornot L, Rochat T, Lacroix JS (2003) Nasal polyps and middle turbinates epithelial cells sensitivity to amphotericin B. Rhinology 41(4):201–205

    PubMed  CAS  Google Scholar 

  14. Jornot L, Rochat T, Caruso A, Lacroix JS (2005) Effects of amphotericin B on ion transport proteins in airway epithelial cells. J Cell Physiol 204(3):859–870

    Article  PubMed  CAS  Google Scholar 

  15. Kennedy, D.W., F.A. Kuhn, D.L. Hamilos, S.J. Zinreich, D. Butler, G. Warsi, P.J. Pfister, and A. Tavakkol, (2005) Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope. 115(10):1793–1799

    Article  PubMed  CAS  Google Scholar 

  16. Ponikau JU, Sherris DA, Kern EB, Homburger HA, Frigas E, Gaffey TA, Roberts GD (1999) The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 74(9): 877–884

    Article  PubMed  CAS  Google Scholar 

  17. Ponikau JU, Sherris DA, Kita H, Kern EB (2002) Intranasal antifungal treatment in 51 patients with chronic rhinosinusitis. J Allergy Clin Immunol 110(6):862–866

    Article  PubMed  CAS  Google Scholar 

  18. Ponikau JU, Sherris DA, Weaver A, Kita H (2005) Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 115(1):125–131

    Article  PubMed  CAS  Google Scholar 

  19. Rains BM III, Mineck CW (2003) Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 17(1):1–8

    PubMed  Google Scholar 

  20. Ricchetti A, Landis BN, Maffioli A, Giger R, Zeng C, Lacroix JS (2002) Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 116(4): 261–263

    Article  PubMed  Google Scholar 

  21. Rogers TR (2006) Antifungal drug resistance: limited data, dramatic impact? Int J Antimicrob Agents 27(suppl 1):7–11

    Article  PubMed  Google Scholar 

  22. Shin SH, Ye MK (2004) Effects of topical amphotericin B on expression of cytokines in nasal polyps. Acta Otolaryngol 124(10): 1174–1177

    Article  PubMed  CAS  Google Scholar 

  23. Shirazi MA, Stankiewicz JA, Kammeyer P (2007) Activity of nasal amphotericin B irrigation against fungal organisms in vitro. Am J Rhinol 21(2):145–148

    Article  PubMed  Google Scholar 

  24. Weschta M, Rimek D, Formanek M, Podbielski A, Riechelmann H (2006) Effect of nasal antifungal therapy on nasal cell activation markers in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 132(7):743–747

    Article  PubMed  Google Scholar 

  25. Weschta M, Rimek D, Formanek M, Polzehl D, Podbielski A, Riechelmann H (2004) Topical antifungal treatment of chronic rhinosinusitis with nasal polyps: a randomized, double-blind clinical trial. J Allergy Clin Immunol 113(6): 1122–1128

    Article  PubMed  CAS  Google Scholar 

  26. Wildfeuer A, Seidl HP, Paule I, Haberreiter A (1998) In vitro evaluation of voriconazole against clinical isolates of yeasts, moulds and dermatophytes in comparison with itraconazole, ketoconazole, amphotericin B and griseofulvin. Mycoses 41(7–8):309–319

    Article  PubMed  CAS  Google Scholar 

  27. Yang YL, Li SY, Cheng HH, Lo HJ (2005) The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan. BMC Infect Dis 5:99

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Roland Giger .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Giger, R., Landis, B.N., Stow, N.W., Lacroix, JS. (2010). Antifungal Treatment (Topical/Systemic). In: Önerci, T., Ferguson, B. (eds) Nasal Polyposis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-11412-0_24

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-11412-0_24

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-11411-3

  • Online ISBN: 978-3-642-11412-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics